About MindBio Therapeutics
MindBio Therapeutics is a company based in Melbourne (Australia) founded in 2021 by Justin Hanka.. MindBio Therapeutics offers products and services including MB22001. MindBio Therapeutics operates in a competitive market with competitors including Celerion, Ask Gene Pharma, Altasciences, iCardiac Technologies and Avance Clinical, among others.
- Headquarter Melbourne, Australia
- Founders Justin Hanka
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mindbio Therapeutics Corp.
-
Annual Revenue
$0 (USD)0as on Jun 30, 2024
-
Net Profit
$-261.77 K (USD)90.23as on Jun 30, 2024
-
EBITDA
$-423.81 K (USD)79.5as on Jun 30, 2024
-
Latest Funding Round
$66.57 K (USD), Post-IPO
May 19, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MindBio Therapeutics
MindBio Therapeutics is a publicly listed company on the CSE with ticker symbol MBIO in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MindBio Therapeutics
MindBio Therapeutics offers a comprehensive portfolio of products and services, including MB22001. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Microdose psychedelic treatment for major depressive disorder.
Funding Insights of MindBio Therapeutics
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $66,573
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Post-IPO - MindBio Therapeutics | Valuation |
investors |
|
| Apr, 2025 | Amount | Post-IPO - MindBio Therapeutics | Valuation |
investors |
|
| Apr, 2025 | Amount | Post-IPO - MindBio Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by MindBio Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MindBio Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mindbio Therapeutics Comparisons
Competitors of MindBio Therapeutics
MindBio Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Ask Gene Pharma, Altasciences, iCardiac Technologies and Avance Clinical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Early clinical research services are provided for drug development.
|
|
| domain | founded_year | HQ Location |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| domain | founded_year | HQ Location |
Early phase clinical research services are provided in North America.
|
|
| domain | founded_year | HQ Location |
Cardiac safety testing and respiratory laboratory services are provided.
|
|
| domain | founded_year | HQ Location |
Clinical development services are provided to pharmaceutical clients worldwide.
|
|
| domain | founded_year | HQ Location |
CRO services for Phase I Clinical Trials, and Core ECG lab services for trials from Phase I to IV
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mindbio Therapeutics
Frequently Asked Questions about MindBio Therapeutics
When was MindBio Therapeutics founded?
MindBio Therapeutics was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Where is MindBio Therapeutics located?
MindBio Therapeutics is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
What does MindBio Therapeutics do?
MindBio Therapeutics was established in 2021 and is based in Melbourne, Australia. Clinical trial services at phase I and II levels are provided, with a focus on mental health diseases within the biotechnology sector. Operations center on developing and testing treatments through structured trial protocols. The company is led by co-founder Justin Hanka, supporting research advancements in psychiatric conditions.
Who are the top competitors of MindBio Therapeutics?
MindBio Therapeutics's top competitors include Celerion, Ask Gene Pharma and Altasciences.
What products or services does MindBio Therapeutics offer?
MindBio Therapeutics offers MB22001.
Is MindBio Therapeutics publicly traded?
Yes, MindBio Therapeutics is publicly traded on CSE under the ticker symbol MBIO.
What is MindBio Therapeutics's ticker symbol?
The ticker symbol of MindBio Therapeutics is MBIO on CSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.